CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: tenofovir disoproxil fumarate
Accession: CHEBI:63718
browse the term
Definition: A fumarate salt prepared from equimolar amounts of tenofovir disoproxil and fumaric acid. It is used in combination therapy for the treatment of HIV infection.
Synonyms: exact_synonym: bis({[(propan-2-yloxy)carbonyl]oxy}methyl) ({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonate (2E)-but-2-enedioate
related_synonym: 9-((R)-2-((bis(((isopropoxycarbonyl)oxy)methoxy)phosphinyl)methoxy)propyl)adenine fumarate; Formula=C23H34N5O14P; InChI=1S/C19H30N5O10P.C4H4O4/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24;5-3(6)1-2-4(7)8/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22);1-2H,(H,5,6)(H,7,8)/b;2-1+/t14-;/m1./s1; InChIKey=VCMJCVGFSROFHV-WZGZYPNHSA-N; SMILES=OC(=O)\\C=C\\C(O)=O.CC(C)OC(=O)OCOP(=O)(CO[C@H](C)Cn1cnc2c(N)ncnc12)OCOC(=O)OC(C)C; TDF; Viread; tenofovir DF
alt_id: MESH:D000068698
xref: CAS:202138-50-9; DrugBank:DB00300; KEGG:D01982
xref_mesh: MESH:D000068698
xref: PMID:12064015; PMID:15482138; PMID:15669881; PMID:18434949; PMID:19372836; PMID:22077579; PMID:22210639; PMID:22928893; PMID:23466649; Reaxys:9831556; Wikipedia:Tenofovir
G
ABCB4
ATP binding cassette subfamily B member 4
decreases activity
EXP
Tenofovir results in decreased activity of ABCB4 protein
CTD
PMID:28437613
NCBI chr 7:87,365,896...87,476,027
Ensembl chr 7:87,401,696...87,480,435
G
ACACB
acetyl-CoA carboxylase beta
affects expression
EXP
Tenofovir affects the expression of ACACB mRNA
CTD
PMID:20032539
NCBI chr12:109,111,189...109,268,226
Ensembl chr12:109,116,587...109,268,226
G
BNIP3L
BCL2 interacting protein 3 like
increases expression
EXP
Tenofovir results in increased expression of BNIP3L protein
CTD
PMID:23640862
NCBI chr 8:26,383,054...26,413,127
Ensembl chr 8:26,383,054...26,505,636
G
CASP3
caspase 3
multiple interactions
ISO
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of CASP3 protein]
CTD
PMID:36309141
NCBI chr 4:184,627,696...184,649,447
Ensembl chr 4:184,627,696...184,650,062
G
CAT
catalase
multiple interactions
ISO
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in decreased activity of CAT protein
CTD
PMID:34118364
NCBI chr11:34,438,934...34,472,060
Ensembl chr11:34,438,934...34,472,060
G
CCL20
C-C motif chemokine ligand 20
increases expression multiple interactions
EXP
Tenofovir results in increased expression of CCL20 mRNA Tenofovir results in increased expression of and results in increased secretion of CCL20 protein
CTD
PMID:24205323
NCBI chr 2:227,813,842...227,817,556
Ensembl chr 2:227,805,739...227,817,564
G
CDKN1A
cyclin dependent kinase inhibitor 1A
increases expression multiple interactions
EXP
Tenofovir results in increased expression of CDKN1A protein [Emtricitabine co-treated with Tenofovir] results in increased expression of CDKN1A protein
CTD
PMID:31545371
NCBI chr 6:36,676,463...36,687,332
Ensembl chr 6:36,676,460...36,687,337
G
CXCL8
C-X-C motif chemokine ligand 8
multiple interactions increases expression
EXP
Tenofovir results in increased expression of and results in increased secretion of CXCL8 protein Tenofovir results in increased expression of CXCL8 mRNA
CTD
PMID:24205323
NCBI chr 4:73,740,569...73,743,716
Ensembl chr 4:73,740,519...73,743,716
G
CYP2C9
cytochrome P450 family 2 subfamily C member 9
decreases activity
EXP
Tenofovir results in decreased activity of CYP2C9 protein
CTD
PMID:17162464
NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
G
CYP2E1
cytochrome P450 family 2 subfamily E member 1
decreases activity
EXP
Tenofovir results in decreased activity of CYP2E1 protein
CTD
PMID:17162464
NCBI chr10:133,527,363...133,539,123
Ensembl chr10:133,520,406...133,561,220
G
DDX3Y
DEAD-box helicase 3 Y-linked
increases expression
ISO
Tenofovir results in increased expression of DDX3Y mRNA
CTD
PMID:37852574
NCBI chr Y:12,903,999...12,920,478
Ensembl chr Y:12,904,108...12,920,478
G
EDN1
endothelin 1
increases secretion multiple interactions
EXP
Tenofovir results in increased secretion of EDN1 protein coenzyme Q10 inhibits the reaction [Tenofovir results in increased secretion of EDN1 protein]
CTD
PMID:23640862
NCBI chr 6:12,230,516...12,297,194
Ensembl chr 6:12,290,361...12,297,194
G
EIF2S1
eukaryotic translation initiation factor 2 subunit alpha
affects phosphorylation
EXP
Tenofovir affects the phosphorylation of EIF2S1 protein
CTD
PMID:27041070
NCBI chr14:67,360,328...67,386,516
Ensembl chr14:67,360,328...67,386,516
G
FGB
fibrinogen beta chain
decreases expression
ISO
Tenofovir results in decreased expression of FGB mRNA
CTD
PMID:37852574
NCBI chr 4:154,562,980...154,572,807
Ensembl chr 4:154,563,011...154,572,807
G
GJC2
gap junction protein gamma 2
increases expression
ISO
Tenofovir results in increased expression of GJC2 mRNA
CTD
PMID:37852574
NCBI chr 1:228,149,930...228,159,826
Ensembl chr 1:228,149,930...228,159,826
G
HAVCR1
hepatitis A virus cellular receptor 1
multiple interactions increases secretion
EXP
Tenofovir inhibits the reaction [cidofovir results in increased secretion of HAVCR1 protein] Tenofovir results in increased secretion of HAVCR1 protein
CTD
PMID:29738843
NCBI chr 5:157,029,413...157,069,407
Ensembl chr 5:157,026,742...157,069,396
G
HSD11B1
hydroxysteroid 11-beta dehydrogenase 1
affects expression
EXP
Tenofovir affects the expression of HSD11B1 mRNA
CTD
PMID:20032539
NCBI chr 1:209,686,179...209,734,929
Ensembl chr 1:209,686,178...209,734,949
G
HSPD1
heat shock protein family D (Hsp60) member 1
affects expression
EXP
Tenofovir affects the expression of HSPD1 protein
CTD
PMID:27041070
NCBI chr 2:197,486,584...197,500,274
Ensembl chr 2:197,486,584...197,516,737
G
IL1B
interleukin 1 beta
multiple interactions
ISO
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of IL1B protein]
CTD
PMID:36309141
NCBI chr 2:112,829,751...112,836,779
Ensembl chr 2:112,829,751...112,836,816
G
IRF4
interferon regulatory factor 4
decreases expression
ISO
Tenofovir results in decreased expression of IRF4 mRNA
CTD
PMID:37852574
NCBI chr 6:391,752...411,443
Ensembl chr 6:391,739...411,443
G
KDM5D
lysine demethylase 5D
increases expression
ISO
Tenofovir results in increased expression of KDM5D mRNA
CTD
PMID:37852574
NCBI chr Y:19,703,865...19,744,726
Ensembl chr Y:19,703,865...19,744,939
G
KLF15
KLF transcription factor 15
decreases expression
ISO
Tenofovir results in decreased expression of KLF15 mRNA
CTD
PMID:37852574
NCBI chr 3:126,288,125...126,357,408
Ensembl chr 3:126,342,635...126,357,408
G
LIPE
lipase E, hormone sensitive type
affects expression
EXP
Tenofovir affects the expression of LIPE mRNA
CTD
PMID:20032539
NCBI chr19:42,401,514...42,427,388
Ensembl chr19:42,401,514...42,427,388
G
LONP1
lon peptidase 1, mitochondrial
affects expression
EXP
Tenofovir affects the expression of LONP1 protein
CTD
PMID:27041070
NCBI chr19:5,691,834...5,720,452
Ensembl chr19:5,691,834...5,720,572
G
LPIN1
lipin 1
decreases expression
ISO
Tenofovir results in decreased expression of LPIN1 mRNA
CTD
PMID:37852574
NCBI chr 2:11,677,544...11,827,409
Ensembl chr 2:11,677,595...11,827,409
G
MAPK8
mitogen-activated protein kinase 8
affects phosphorylation
EXP
Tenofovir affects the phosphorylation of MAPK8 protein
CTD
PMID:27041070
NCBI chr10:48,306,677...48,439,360
Ensembl chr10:48,306,639...48,439,360
G
MPO
myeloperoxidase
multiple interactions
ISO
[efavirenz co-treated with Lamivudine co-treated with Tenofovir] promotes the reaction [[isoniazid, pyrazinamide, rifampin drug combination co-treated with Ethambutol] results in increased activity of MPO protein]; [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased activity of MPO protein
CTD
PMID:34118364
NCBI chr17:58,269,855...58,280,935
Ensembl chr17:58,269,855...58,280,935
G
MT-CO2
mitochondrially encoded cytochrome c oxidase II
multiple interactions
EXP
Tenofovir promotes the reaction [Didanosine results in decreased expression of COX2 mRNA]
CTD
PMID:16940060
NCBI chr MT:7,586...8,269
Ensembl chr MT:7,586...8,269
G
NFKBIA
NFKB inhibitor alpha
decreases expression
ISO
Tenofovir results in decreased expression of NFKBIA protein
CTD
PMID:27899301
NCBI chr14:35,401,513...35,404,749
Ensembl chr14:35,401,079...35,404,749
G
NOS2
nitric oxide synthase 2
increases expression
ISO
Tenofovir results in increased expression of NOS2 mRNA; Tenofovir results in increased expression of NOS2 protein
CTD
PMID:27899301
NCBI chr17:27,756,766...27,800,529
Ensembl chr17:27,756,766...27,800,529
G
NOS3
nitric oxide synthase 3
multiple interactions decreases phosphorylation
EXP
coenzyme Q10 inhibits the reaction [Tenofovir results in decreased phosphorylation of NOS3 protein]
CTD
PMID:23640862
NCBI chr 7:150,991,017...151,014,588
Ensembl chr 7:150,991,017...151,014,588
G
NR3C1
nuclear receptor subfamily 3 group C member 1
affects expression
EXP
Tenofovir affects the expression of NR3C1 mRNA
CTD
PMID:20032539
NCBI chr 5:143,277,931...143,435,512
Ensembl chr 5:143,277,931...143,435,512
G
NT5E
5'-nucleotidase ecto
increases expression
EXP
Tenofovir results in increased expression of NT5E mRNA
CTD
PMID:24205323
NCBI chr 6:85,450,083...85,495,784
Ensembl chr 6:85,449,584...85,495,791
G
NT5M
5',3'-nucleotidase, mitochondrial
decreases expression
EXP
Tenofovir results in decreased expression of NT5M mRNA
CTD
PMID:24205323
NCBI chr17:17,303,373...17,347,663
Ensembl chr17:17,303,335...17,347,663
G
PPARG
peroxisome proliferator activated receptor gamma
affects expression
EXP
Tenofovir affects the expression of PPARG mRNA
CTD
PMID:20032539
NCBI chr 3:12,287,368...12,434,344
Ensembl chr 3:12,287,368...12,434,356
G
PRKN
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
[Emtricitabine co-treated with Tenofovir] results in decreased expression of PRKN protein
CTD
PMID:31545371
NCBI chr 6:161,347,417...162,727,766
Ensembl chr 6:161,347,417...162,727,775
G
PTGS2
prostaglandin-endoperoxide synthase 2
increases expression
ISO
Tenofovir results in increased expression of PTGS2 mRNA; Tenofovir results in increased expression of PTGS2 protein
CTD
PMID:27899301
NCBI chr 1:186,671,791...186,680,423
Ensembl chr 1:186,671,791...186,680,922
G
RELA
RELA proto-oncogene, NF-kB subunit
multiple interactions affects localization increases expression
ISO
Melatonin inhibits the reaction [Tenofovir affects the localization of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of and results in increased activity of RELA protein]; Melatonin inhibits the reaction [Tenofovir results in increased expression of RELA mRNA]; Tenofovir results in increased expression of and results in increased activity of RELA protein
CTD
PMID:27899301
NCBI chr11:65,653,601...65,663,857
Ensembl chr11:65,653,599...65,663,090
G
SIRT3
sirtuin 3
increases expression
EXP
Tenofovir results in increased expression of SIRT3 protein
CTD
PMID:27041070
NCBI chr11:215,030...236,931
Ensembl chr11:215,030...236,931
G
SLC22A6
solute carrier family 22 member 6
increases response to substance increases import multiple interactions
EXP
SLC22A6 protein results in increased susceptibility to Tenofovir SLC22A6 protein results in increased import of Tenofovir Probenecid inhibits the reaction [SLC22A6 protein results in increased susceptibility to Tenofovir]; SLC22A6 protein results in increased uptake of and results in increased susceptibility to Tenofovir; Tenofovir inhibits the reaction [SLC22A6 protein results in increased uptake of p-Aminohippuric Acid]
CTD
PMID:23856525 PMID:25448811 PMID:29738843
NCBI chr11:62,976,597...62,984,967
Ensembl chr11:62,936,385...62,984,967
G
SLC22A8
solute carrier family 22 member 8
increases response to substance increases import
EXP
SLC22A8 protein results in increased susceptibility to Tenofovir SLC22A8 protein results in increased import of Tenofovir
CTD
PMID:25448811 PMID:29738843
NCBI chr11:62,992,824...63,015,841
Ensembl chr11:62,989,154...63,015,841
G
TNF
tumor necrosis factor
decreases expression multiple interactions increases expression
EXP ISO
Tenofovir results in decreased expression of TNF mRNA [efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein; Zinc inhibits the reaction [[efavirenz co-treated with Lamivudine co-treated with Tenofovir] results in increased expression of TNF protein] Tenofovir results in increased expression of TNF mRNA; Tenofovir results in increased expression of TNF protein
CTD
PMID:24205323 PMID:27899301 PMID:36309141
NCBI chr 6:31,575,565...31,578,336
Ensembl chr 6:31,575,565...31,578,336
G
TP53
tumor protein p53
multiple interactions increases expression
EXP
[Emtricitabine co-treated with Tenofovir] results in increased expression of TP53 protein Tenofovir results in increased expression of TP53 protein
CTD
PMID:31545371
NCBI chr17:7,668,421...7,687,490
Ensembl chr17:7,661,779...7,687,538
G
USP18
ubiquitin specific peptidase 18
increases expression
ISO
Tenofovir results in increased expression of USP18 mRNA
CTD
PMID:37852574
NCBI chr22:18,150,170...18,177,397
Ensembl chr22:18,150,118...18,177,397
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all